Kim Kardashian boosting morning sickness pill irks FDA

While Kim Kardashian is no stranger to using social media to promote her endorsements, her boosting a morning sickness pill — without including a mention of side effects — drew criticism from the federal Food and Drug Administration.

It all started when the reality TV star posted a photo of herself last month on Twitter and Instagram — holding a bottle of Diclegis, a drug produced by Duschenay Inc. Along with the photo Kardashian wrote, “OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby.”

That led to FDA officials to post a letter on its website stating Kardashian’s post violated regulations because she never mentioned potential side effects, which include drowsiness. “The FDA has reviewed the Kim Kardashian Social Media Post,” the agency wrote. “The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information.”

Since then, Kardashian has deleted her social media posts.